Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70685 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Transplantation, 2026. Verfasst von Ishaan P Dharia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) is uncommon but associated with poor outcomes, requiring effective surveillance. We assessed adherence to and effectiveness of a risk‐stratified surveillance protocol and compared it with the RETREAT‐guided surveillance protocol.
Methods
We performed a single‐center retrospective review of patients with HCC on explant after LT (2013–2023). Patients were assigned low‐ or high‐risk surveillance based on explant pathology (AJCC tumor stage, grade, and vascular invasion). Protocol performance, modified surveillance strategies, and comparison with RETREAT across multiple cutoffs were assessed.
Results
Among 480 patients, 55 (11.5%) developed recurrence; 23 (41.8%) of these died, with median post‐recurrence survival of 14 months. Only 15.8% were fully adherent, with higher adherence in low‐risk patients ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Recanati Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, USA.
- Department of Pathology, Mount Sinai West and Morningside, New York, New York, USA.
- Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zitieren
APA
Dharia, I. P., Leven, E. A., Schmidt, N., Waite, H., Ni, P., Fiel, M. I., Facciuto, M. E., Schiano, T. D., & Grinspan, L. T. (2026). Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol. Clinical Transplantation. https://doi.org/10.1111/ctr.70685
Vancouver
Dharia IP, Leven EA, Schmidt N, Waite H, Ni P, Fiel MI, et al. Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol. Clinical Transplantation. 2026. doi:10.1111/ctr.70685
BibTeX
@article{Dharia2026,
author = {Dharia, Ishaan P and Leven, Emily A and Schmidt, Natalia and Waite, Haley and Ni, Pu and Fiel, M Isabel and Facciuto, Marcelo E and Schiano, Thomas D and Grinspan, Lauren T},
title = {Risk‐Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT‐Guided Surveillance Protocol},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70685}
}
EUVIMED